New drug combo shrinks tumors in most patients facing aggressive cancer type
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.

Read at Fox News(opens in a new tab)
Full coverage
New drug combo shrinks tumors in most patients facing aggressive cancer type (opens Fox News in a new tab)
The pancreatic cancer pill daraxonrasib shrank tumors in 60.7% of patients when paired with chemotherapy, with 8.2% seeing tumors vanish on scans.
